SOURCE: ProActive Capital Group
NEW YORK, NY--(Marketwired - Mar 11, 2014) - ProActive Capital Group (PCG), a leading capital market advisory and communications firm, announced today that it has partnered with the Alliance for Regenerative Medicine (ARM) for its Regen Med Investor Day 2014. The day-long event will take place on March 26, 2014 at the Metropolitan Club and is co-hosted by financial firms Piper Jaffray and Maxim Group. Expected to attract over 350 investors, members of the media and the field's top executives, the 2014 meeting has expanded to include 32 company presentations, three analyst-led panels highlighting the sector's key opinion leaders and featured speakers.
"We are pleased to partner with ARM for this year's event," said Jeff Ramson, Founder and CEO of ProActive Capital Group. "The Regen Med Investor Day has quickly become a 'must attend' event for companies in regenerative medicine, bringing together some of the most passionate leaders and thinkers in this space."
To visit the conference website, please use the following address:
http://arminvestorday.com/ Credentialed investors, life science strategic partners and members of the media should contact Laura Parsons at firstname.lastname@example.org if interested in attending.
The following PCG clients will be presenting and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. If you are interested in speaking with any of these companies, please contact Adam Holdsworth at ProActive Capital Group -- 646-862-4607.
- Mesoblast (MBLTY): 12:30pm Lunch Keynote Presentation by Dr. Silviu Itescu
- NeoStem (NBS): 1:00pm | West Lounge Room
- Prima BioMed (PBMD): 1:15pm | Main Bar Room
- Athersys (ATHX): 1:30pm | West Lounge Room
- Harvard Apparatus (HART): 1:30pm | Main Bar Room
- Cesca Therapeutics (KOOL): 5:00pm | West Lounge Room
Follow PCG during the event for live updates on twitter: @proactive_news #RMDay14
About ProActive Capital Group, LLC
ProActive Capital Group, LLC ("PCG") is a leading capital market advisory and communications firm dedicated to the discovery and creation of value in the emerging public company marketplace. The firm's overarching goal is to develop and maintain stakeholder awareness from all constituents in order to maximize shareholder value. PCG's capital market advisory services include key strategies to increase corporate transparency and credibility for companies across all sectors. The firm's communications services leverage traditional, digital and social media channels to further increase awareness through proprietary and best-of-breed media strategies. Communicating the client's story accurately and effectively is tantamount to maximizing exposure to its current and potential shareholders. For more information: www.proactivecapital.com.
Follow us on twitter @proactive_news
About The Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, DC to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 150 members and is the leading global advocacy organization in this field. To learn more about ARM or to become a member, visit www.alliancerm.org.
Follow ARM on twitter @alliancerm